Company Data
Delcath Systems Inc.
Ticker
DCTH
Current Price
$14.88 -4.25%
Market Cap
$475.8M
Price Target
Refer to Report
Volume
240.3K
52wk Range
$3.7 - $16.97
Overview
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm’s product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.